Publicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (9)

2020

  1. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)

    Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 236-244

2019

  1. Treatment and outcome of patients with stage is testicular cancer: A retrospective study from the Spanish germ cell cancer group

    Journal of Urology, Vol. 202, Núm. 4, pp. 742-747

2018

  1. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study

    European Journal of Cancer, Vol. 101, pp. 263-272

  2. Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer

    International Journal of Cancer, Vol. 143, Núm. 8, pp. 1954-1962

2017

  1. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer

    European Urology Focus, Vol. 3, Núm. 2-3, pp. 280-286

  2. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 4, pp. 498-507

  3. Prognostic significance of venous thromboembolic events in disseminated germ cell cancer patients

    Journal of the National Cancer Institute, Vol. 109, Núm. 4

2014

  1. Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base

    Clinical and Translational Oncology, Vol. 16, Núm. 11, pp. 959-965

2008

  1. Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

    European Journal of Cancer, Vol. 44, Núm. 9, pp. 1229-1237